Compass Therapeutics, Inc. (CMPX)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 4/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in Compass Therapeutics, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Compass Therapeutics, Inc. (CMPX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies REVOLUTION MEDICINES INC (RVMD) as the most exposed collateral stock, sharing 1 ETFs with CMPX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CMPX Ownership Dynamics
ETFs with Highest CMPX Exposure
Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 35 | $1.97 | $68.95 |
| 2026-05-12 | 102,145 | $1.83 | $186,925.35 |
| 2026-05-08 | 1,450,764 | $1.81 | $2.6M |
| 2026-05-06 | 104,809 | $1.95 | $204,377.55 |
| 2026-05-04 | 208,262 | $1.96 | $408,193.52 |
| 2026-05-01 | 14,694 | $1.77 | $26,008.38 |
| 2026-04-20 | 99,932 | $6.00 | $599,592 |
| 2026-04-17 | 93,631 | $6.53 | $611,410.43 |
| 2026-03-26 | 8,578 | $5.49 | $47,093.22 |
| 2026-03-25 | 14 | $5.33 | $74.62 |
| 2026-03-24 | 3,000 | $5.04 | $15,120 |
| 2026-03-18 | 173 | $5.45 | $942.85 |
| 2026-03-11 | 98,476 | $5.57 | $548,511.32 |
| 2026-03-10 | 96,535 | $5.42 | $523,219.7 |
| 2026-03-06 | 76,198 | $5.53 | $421,374.94 |
| 2026-03-04 | 20 | $5.53 | $110.6 |
| 2026-03-03 | 154 | $5.68 | $874.72 |
| 2026-02-13 | 16,435 | $6.34 | $104,197.9 |
| 2026-02-12 | 20,880 | $6.44 | $134,467.2 |
| 2026-02-11 | 23,616 | $6.60 | $155,865.6 |
| 2026-01-27 | 450,143 | $6.19 | $2.8M |
| 2026-01-23 | 98,184 | $6.27 | $615,613.68 |
| 2026-01-22 | 133,511 | $5.90 | $787,714.9 |
| 2026-01-15 | 10,100 | $6.04 | $61,004 |
| 2026-01-13 | 1,213 | $5.21 | $6,319.73 |
| 2026-01-08 | 38 | $5.45 | $207.1 |
| 2025-12-22 | 13,102 | $4.99 | $65,378.98 |
| 2025-12-05 | 45,983 | $5.54 | $254,745.82 |
| 2025-12-02 | 90,538 | $5.46 | $494,337.48 |
| 2025-12-01 | 95,046 | $5.80 | $551,266.8 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare CMPX to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.